Skip to main content
SpringerLink
Log in

New warnings for gadolinium-containing contrast agents

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. FDA.FDA Drug Safety Communication: new warnings for using gadolinium-based contrast agents in patients with kidney dysfunction. Internet Document: [2 pages], 9 Sep 2010. Available from: URL: http://www.fda.gov

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

New warnings for gadolinium-containing contrast agents. React. Wkly. 1319, 2 (2010). https://doi.org/10.2165/00128415-201013190-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201013190-00002

Keywords

Search

Navigation